Category: Neutrophil Count

Hematological Markers as Predictors of ICU Admission in COVID-19 Patients: A Case-Control Study From a Tertiary Hospital

Posted on | Posted on John Murphy | Leave a Comment on Hematological Markers as Predictors of ICU Admission in COVID-19 Patients: A Case-Control Study From a Tertiary Hospital

Nor Hayati Ismail • Alaa Siddig • Muhammad ‘Akif, et. al. Published: July 10, 2024, DOI: 10.7759/cureus.64213  Abstract Background: COVID-19 illness severity ranges from mild- to life-threatening cases necessitating critical care. Rapid prediction of disease severity and the need for critical care support in COVID-19 patients remain essential, not only for current management but also for preparedness in future pandemics. This […]

Retrospective Evaluation of Hematological Parameters in COVID-19 Patients: Insights From the Emergency Department

Posted on | Posted on John Murphy | Leave a Comment on Retrospective Evaluation of Hematological Parameters in COVID-19 Patients: Insights From the Emergency Department

Ahmed Jerah, May 28, 2024, DOI: 10.7759/cureus.61258 Cite this article as: Jerah A (May 28, 2024) Retrospective Evaluation of Hematological Parameters in COVID-19 Patients: Insights From the Emergency Department. Cureus 16(5): e61258. doi:10.7759/cureus.61258 Abstract Background: This retrospective study evaluated hematological parameters in coronavirus disease 2019 (COVID-19) patients to gain clinical insights. Methods: Data from the Emergency Department of Samtah […]

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19

Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , * Front Immunol. 2022; 13: 857573.  Apr 27.  2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561 Abstract Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of clinical manifestations, with progression to multiorgan failure in the most severe cases. Several biomarkers can be altered […]